Equities

BIOLASE Inc

BIOLASE Inc

Actions
  • Price (USD)0.09
  • Today's Change-0.01 / -10.00%
  • Shares traded174.73k
  • 1 Year change-98.83%
  • Beta0.7186
Data delayed at least 15 minutes, as of Jul 05 2024 20:57 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

BIOLASE, Inc. is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company's systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. It offers two categories of laser system products: Waterlase (all-tissue) systems and diode (soft-tissue) systems. The Company's all-tissue Waterlase dental laser systems consist of its flagship Waterlase iPlus, Waterlase Express, and Waterlase MDX. Its soft tissue diode laser systems consist of the Epic X, Epic Hygiene, Epic Q, and Epic 10 diode lasers that perform soft tissue, hygiene, cosmetic procedures, teeth whitening, and provide temporary pain relief. Epic X, and Epic 10 systems feature its 940 nanometer wavelength with patented pulse technology called ComfortPulse.

  • Revenue in USD (TTM)48.83m
  • Net income in USD-38.26m
  • Incorporated1987
  • Employees157.00
  • Location
    BIOLASE Inc27042 Towne Centre Drive, Suite 270FOOTHILL RANCH 92610United StatesUSA
  • Phone+1 (949) 361-1200
  • Fax+1 (949) 273-6677
  • Websitehttps://www.biolase.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
InnerScope Hearing Technologies, Inc.334.45k-7.15m2.14m24.00------6.40-0.0153-0.01530.0002-0.00280.09553.931.71---204.11-27.82---94.5317.7958.17-2,138.50-42.130.0022-0.4232------100.59----233.50--
Tivic Health Systems Inc1.13m-7.61m2.28m9.00--0.252--2.01-11.17-11.171.021.460.21840.923717.31126,000.00-146.51---194.55--30.07---670.99--2.07--0.00---36.09--18.34------
LumiraDx Ltd126.52m-338.03m2.30m1.21k------0.0182-1.08-1.080.4021-1.310.27651.792.44104,557.90-73.83---96.82---80.48---267.03--1.01-10.512.14---39.62---343.67------
Helius Medical Technologies Inc-100.00bn-100.00bn2.34m26.00--0.4139----------2.24-----------98.37---143.57--37.27---1,580.663.26-------18.176.1437.11------
Bioelectronics Corp1.61m-289.82k2.47m9.00------1.53-0.00002-0.000020.00007-0.00066.329.2014.53---113.86-383.59----49.4351.48-18.01-143.480.0099-0.4909----94.01-5.0975.01------
Catheter Precision Inc439.00k-6.85m2.68m14.00--0.1447--6.11-1.03-1.030.06592.450.01150.37595.7431,357.14-17.89---19.64--94.31---1,559.68--0.8047--0.004--3,057.14---165.67------
SINTX Technologies Inc2.78m-8.88m2.76m43.00--0.0117--0.9949-389.94-389.9474.21383.240.1381.625.8464,534.88-44.03-45.71-57.11-57.3667.9658.47-318.99-681.801.67--0.0229--68.2994.2449.75--54.10--
Tenon Medical Inc3.21m-14.33m2.78m21.00--8.57--0.8644-7.24-7.241.430.97240.41082.787.25153,047.60-183.10---269.43--54.70---445.77--2.35--0.00--323.73--17.63------
Heart Test Laboratories Inc18.60k-6.39m2.89m12.00--32.49--155.44-0.4912-0.49120.00090.13570.00260.0092.531,550.00-89.51---120.71--67.31---34,362.42--4.70-16.410.0547---64.16---31.61------
Vycor Medical Inc1.44m-425.52k2.93m8.00------2.04-0.0133-0.01350.0425-0.10781.590.66726.81179,572.50-11.22-47.86----89.4889.60-7.04-35.420.0861-0.0247----19.43-0.654246.49---31.77--
Avinger Inc7.62m-16.13m2.97m68.00------0.3897-18.16-18.167.49-2.560.40841.206.38112,102.90-102.83-70.93---131.5722.4330.87-251.78-208.910.4764-10.021.38---7.51-0.673632.76---24.21--
Invo Bioscience Inc4.25m-7.08m2.97m25.00------0.6992-5.68-5.682.590.00390.34739.5030.72169,953.20-57.87-94.63-128.00-151.4539.9074.91-166.64-343.110.1629-5.860.9965--267.3843.6226.24--87.09--
BIOLASE Inc48.83m-38.26m3.01m157.00------0.0616-20.50-20.508.640.00811.282.219.00311,006.40-55.75-49.28-118.58-85.8034.2535.27-43.56-50.720.6409-5.980.9812--1.451.27-30.39--18.63--
Optimus Healthcare Services Inc1.57m-8.57m3.16m12.00------2.01-0.2139-0.21390.039-0.18840.9263--3.12130,884.20-505.59------83.03---545.81-----7.49----22.88---3.51------
AccuStem Sciences Inc0.00-1.74m3.87m3.00---------0.1537-0.15370.00-0.23090.00----0.00-1,168.46--------------------------45.26------
Data as of Jul 05 2024. Currency figures normalised to BIOLASE Inc's reporting currency: US Dollar USD

Institutional shareholders

5.01%Per cent of shares held by top holders
HolderShares% Held
S.H.N. Financial Investments Ltd.as of 13 Feb 20241.19m3.56%
Virtu Americas LLCas of 31 Mar 2024143.54k0.43%
HRT Financial LLCas of 31 Mar 2024101.14k0.30%
XTX Markets LLCas of 31 Mar 202473.08k0.22%
RBC Dominion Securities, Inc. (Investment Management)as of 31 Mar 202450.00k0.15%
Citadel Securities LLCas of 31 Mar 202439.83k0.12%
G1 Execution Services LLCas of 31 Mar 202436.65k0.11%
Kellett Wealth Advisors LLCas of 31 Mar 202419.06k0.06%
The Vanguard Group, Inc.as of 31 May 202410.91k0.03%
Jane Street Capital LLCas of 31 Mar 202410.11k0.03%
More ▼
Data from 31 Mar 2024 - 04 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.